REVB Earnings

Quarterly EPS
$-416.25
Q4 2024
$-177.38
Q1 2025
$-196.28
Q2 2025
$-49.51
Q3 2025
$-11.41
Q4 2025
$-18.97
Q1 2026
$-6.09
Q2 2026
$-5.92
Q3 2026
Latest RevenueN/A
Latest Net Income-3315513
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$5.920-3315513—+88.0%
Q2 2026-$6.090-3323384—+96.9%
Q1 2026-$18.970-3009051—+89.3%
Q4 2025-$11.410-2511006—+97.3%
Q3 2025-$49.510-1907176—+95.6%
Q2 2025-$196.280-2444382—+97.2%
Q1 2025-$177.380-2051085—+94.6%
Q4 2024-$416.250-1725719—+96.3%
Q3 2024-$1,124.200-2241565——
Q2 2024-$6,895.560-8389819——
Q1 2024-$3,307.080-2681433——
Q4 2023-$11,234.650-2202903——
Revelation Biosciences (REVB) — Earnings